Teleflex Incorporated, headquartered in Wayne, Pennsylvania, is an American provider of specialty medical devices for a range of procedures in critical care and surgery. Teleflex has annual revenues of $2.4 billion, operations in 40 countries, and more than 15,000 employees. By 2011, the company had substantially realigned to focus on its current business as a medical-device manufacturer, having undergone several years of active acquisitions and divestitures. Teleflex has been associated with Irish corporate tax avoidance tools. Teleflex's chief executive officer (CEO) is Liam J. Kelly; Kelly is also the company's president and former chief operating officer.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| TFX | TELEFLEX INC | 2025-10-30 16:09:38 | 125.5 | 0.66 | 0.53 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TFX | 0000096943 | TELEFLEX INC | US8793691069 | UUL85LWXB4NGSWWXIQ25 | 231147939 | NYSE | 3841 | Surgical & Medical Instruments & Apparatus | 1231 | DE | 550 E SWEDESFORD RD | WAYNE | PA | 19087 | UNITED STATES | US | 610-225-6800 | 550 E SWEDESFORD RD, WAYNE, PA, 19087 | 550 E SWEDESFORD RD, WAYNE, PA, 19087 | — | — | 1943 | Liam J. Kelly | 15,000 | http://teleflex.com | 4,278,187,198 | 48,096,000 | 44,192,817 | Teleflex Incorporated, headquartered in Wayne, Pennsylvania, is an American provider of specialty medical devices for a range of procedures in critical care and surgery. Teleflex has annual revenues of $2.4 billion, operations in 40 countries, and more than 15,000 employees. By 2011, the company had substantially realigned to focus on its current business as a medical-device manufacturer, having undergone several years of active acquisitions and divestitures. Teleflex has been associated with Irish corporate tax avoidance tools. Teleflex's chief executive officer (CEO) is Liam J. Kelly; Kelly is also the company's president and former chief operating officer. | 2025-10-30 13:19:18 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2024 | 4,278,187,198 | -1,355,903,129 | -24.0661 | 46,366,463 | -690,019 | -1.4664 |
| 2023 | 5,634,090,327 | -1,356,471,787 | -19.4043 | 47,056,482 | 112,327 | 0.2393 |
| 2022 | 6,990,562,114 | -5,004,769,497 | -41.7226 | 46,944,155 | 74,141 | 0.1582 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| James P. Winters | Corporate Vice President | 2024 | 428,167 | 33,568 | 537,258 | 313,073 | 72,082 | 2,050,486 |
| Thomas E. Powell | Executive Vice President | 2024 | 659,475 | 49,461 | 959,709 | 516,646 | 181,930 | 3,560,335 |
| Liam J. Kelly | Chief Executive Officer, Chairman, President | 2024 | 1,106,950 | 138,369 | 2,744,215 | 1,445,344 | 358,212 | 9,204,397 |
| Jay K. White | Corporate Vice President, President | 2024 | 626,800 | 39,489 | 548,532 | 458,311 | 82,254 | 2,437,165 |
| Daniel V. Logue | Secretary, Corporate Vice President, General Counsel | 2024 | 435,675 | 30,497 | 532,556 | 318,562 | 57,202 | 2,036,411 |
| Fiscal Year | Employee Count |
|---|---|
| 2024 | 14,100 |
| 2023 | 14,500 |
| 2022 | 15,500 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 3,047,324,000 | 2,974,489,000 | 2,791,041,000 |
| Cost Of Revenue | 1,344,645,000 | 1,327,558,000 | 1,259,954,000 |
| Gross Profit | 1,702,679,000 | 1,646,931,000 | 1,531,087,000 |
| Research And Development Expenses | 161,672,000 | 154,351,000 | 153,819,000 |
| General And Administrative Expenses | 995,271,000 | 929,867,000 | 863,748,000 |
| Operating Expenses | — | — | — |
| Operating Income | 151,013,000 | 506,313,000 | 499,725,000 |
| Net Income | 69,675,000 | 356,328,000 | 363,139,000 |
| Earnings Per Share Basic | 1.49 | 7.58 | 7.74 |
| Earnings Per Share Diluted | 1.48 | 7.53 | 7.68 |
| Weighted Average Shares Outstanding Basic | 46,837,000 | 46,981,000 | 46,898,000 |
| Weighted Average Shares Outstanding Diluted | 47,094,000 | 47,304,000 | 47,309,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Cash And Cash Equivalents | 290,188,000 | 222,848,000 | 292,034,000 |
| Marketable Securities Current | — | — | — |
| Accounts Receivable | 459,495,000 | 443,467,000 | 408,834,000 |
| Inventories | 600,133,000 | 626,216,000 | 578,507,000 |
| Non Trade Receivables | — | — | — |
| Other Assets Current | — | — | — |
| Total Assets Current | 1,471,124,000 | 1,407,406,000 | 1,410,983,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 502,852,000 | 479,913,000 | 447,205,000 |
| Other Assets Non Current | 102,624,000 | 98,943,000 | 89,367,000 |
| Total Assets Non Current | 5,626,790,000 | 6,125,140,000 | 5,517,080,000 |
| Total Assets | 7,097,914,000 | 7,532,546,000 | 6,928,063,000 |
| Accounts Payable | 141,031,000 | 132,247,000 | 126,807,000 |
| Deferred Revenue | — | — | — |
| Short Term Debt | 100,000,000 | 87,500,000 | 87,500,000 |
| Other Liabilities Current | 67,243,000 | 46,547,000 | 63,381,000 |
| Total Liabilities Current | 649,360,000 | 606,745,000 | 581,492,000 |
| Long Term Debt | 1,655,871,000 | 1,815,072,000 | 1,711,523,000 |
| Other Liabilities Non Current | 102,307,000 | 162,502,000 | 154,058,000 |
| Total Liabilities Non Current | 2,170,414,000 | 2,484,813,000 | 2,324,603,000 |
| Total Liabilities | 2,819,774,000 | 3,091,558,000 | 2,906,095,000 |
| Common Stock | 48,096,000 | 48,046,000 | 47,957,000 |
| Retained Earnings | 4,115,870,000 | 4,109,736,000 | 3,817,304,000 |
| Accumulated Other Comprehensive Income | -316,669,000 | -314,405,000 | -403,522,000 |
| Total Shareholders Equity | 4,278,140,000 | 4,440,988,000 | 4,021,968,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Depreciation And Amortization | 274,601,000 | 242,118,000 | 230,590,000 |
| Share Based Compensation Expense | 31,348,000 | 31,465,000 | 27,224,000 |
| Other Non Cash Income Expense | — | — | — |
| Change In Accounts Receivable | 27,952,000 | 15,763,000 | 38,459,000 |
| Change In Inventories | -1,925,000 | 41,068,000 | 110,686,000 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | 9,665,000 | -31,258,000 | -24,786,000 |
| Change In Other Liabilities | — | — | — |
| Cash From Operating Activities | 638,260,000 | 511,683,000 | 342,806,000 |
| Purchases Of Marketable Securities | 7,300,000 | 11,300,000 | 22,300,000 |
| Sales Of Marketable Securities | 7,300,000 | 7,300,000 | 7,300,000 |
| Acquisition Of Property Plant And Equipment | 126,434,000 | 91,442,000 | 79,190,000 |
| Acquisition Of Business | — | — | — |
| Other Investing Activities | — | — | — |
| Cash From Investing Activities | 0 | 0 | 1,469,000 |
| Tax Withholding For Share Based Compensation | — | — | 4,308,000 |
| Payments Of Dividends | 63,541,000 | 63,896,000 | 63,789,000 |
| Issuance Of Common Stock | — | — | — |
| Repurchase Of Common Stock | 201,895,000 | — | — |
| Issuance Of Long Term Debt | 130,000,000 | 646,000,000 | 744,250,000 |
| Repayment Of Long Term Debt | 291,500,000 | 544,750,000 | 884,500,000 |
| Other Financing Activities | — | — | — |
| Cash From Financing Activities | -421,925,000 | 38,540,000 | -217,506,000 |
| Change In Cash | 104,802,000 | -69,186,000 | -153,050,000 |
| Cash At End Of Period | 290,188,000 | 222,848,000 | 292,034,000 |
| Income Taxes Paid | 164,902,000 | 114,211,000 | 162,046,000 |
| Interest Paid | 98,376,000 | 100,218,000 | 70,918,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Earnings Per Share | 1.49 | 7.58 | 7.74 |
| Price To Earnings Ratio | 119.4497 | 32.8945 | 32.2519 |
| Earnings Growth Rate | -80.343 | -2.0672 | -25.4335 |
| Price Earnings To Growth Ratio | -1.4867 | -15.9127 | -1.2681 |
| Book Value Per Share | 91.341 | 94.5273 | 85.7599 |
| Price To Book Ratio | 1.9485 | 2.6378 | 2.9108 |
| Ebitda | 592,722,000 | 797,739,000 | 810,039,000 |
| Enterprise Value | 9,801,732,260 | 13,393,966,540 | 13,214,136,740 |
| Dividend Yield | 0.0076 | 0.0055 | 0.0054 |
| Dividend Payout Ratio | 0.912 | 0.1793 | 0.1757 |
| Debt To Equity Ratio | 0.4104 | 0.4284 | 0.4473 |
| Capital Expenditures | 297,540,000 | 274,826,000 | 234,037,000 |
| Free Cash Flow | 340,720,000 | 236,857,000 | 108,769,000 |
| Return On Equity | 0.0163 | 0.0802 | 0.0903 |
| One Year Beta | 0.6414 | 1.0487 | 0.8988 |
| Three Year Beta | 0.8761 | 0.9311 | 0.9597 |
| Five Year Beta | 0.9421 | 0.9618 | 0.9582 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| HAGGERTY GRETCHEN R | Director | 2025-08-06 | 200 | A | 6,005 |
| HAGGERTY GRETCHEN R | Director | 2025-08-06 | 300 | A | 6,305 |
| Ryu Jaewon | Director | 2025-08-05 | 1,500 | A | 3,727 |
| Kelly Liam | Director, Chairman, President & CEO | 2025-08-05 | 1,500 | A | 45,267 |
| Krakauer Andrew A | Director | 2025-08-05 | 1,000 | A | 7,192 |
| Name Of Reporting Person | Type Of Reporting Person | Report Date | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Susan M Collins | Senator | 2014-12-01 | Purchase | 2014-11-10 | Spouse | $15,001 - $50,000 |
| Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Lisa McClain | 2025-08-13 | MI09 | Sale | 2025-07-22 | Spouse | $1,001 - $15,000 |
| Lisa McClain | 2025-08-13 | MI09 | Purchase | 2025-07-16 | Spouse | $1,001 - $15,000 |
| Rob Bresnahan | 2025-03-27 | PA08 | Sale | 2025-02-25 | — | $1,001 - $15,000 |
| Daniel Goldman | 2023-08-13 | NY10 | Sale | 2023-07-12 | — | $15,001 - $50,000 |
| Daniel Goldman | 2023-05-19 | NY10 | Purchase | 2023-04-10 | — | $15,001 - $50,000 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| Westfuller Advisors, LLC | 2025-09-30 | 2,670 | 22 | 121.3636 |
| TEACHER RETIREMENT SYSTEM OF TEXAS | 2025-09-30 | 1,634,118 | 13,355 | 122.36 |
| Parkside Financial Bank & Trust | 2025-09-30 | 10,034 | 82 | 122.3659 |
| STRS OHIO | 2025-09-30 | 2,821,132 | 23,056 | 122.36 |
| MOUNTAIN PACIFIC INVESTMENT ADVISERS LLC | 2025-09-30 | 1,389,275 | 11,354 | 122.36 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| HEARTLAND GROUP INC | 2025-09-30 | Institutional Class | HNTVX | 150,000 | 18,354,000 | 2.1272 |
| HEARTLAND GROUP INC | 2025-09-30 | Investor Class | HRTVX | 150,000 | 18,354,000 | 2.1272 |
| SHELTON FUNDS | 2025-08-31 | K Shares | SMLKX | 1,606 | 203,014.46 | 0.3926 |
| SHELTON FUNDS | 2025-08-31 | Investor Shares | SMCIX | 1,606 | 203,014.46 | 0.3926 |
| Global X Funds | 2025-08-31 | Global X U.S. Cash Flow Kings 100 ETF | FLOW | 706 | 89,245.46 | 0.371 |